Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Absurdly broad stem cell patents are shutting down promising research.
DuPont’s energetic chairman is reinventing the nearly 200-year-old chemical company, shifting its emphasis to biology-based materials and electronic displays.
Wireless sensors probe the infrastructure.
The philosophers got it wrong: scientists love new ideas-if they’re right.
Medicine: New imagers offer an unprecedented view.
With research on embryonic stem cells mired in controversy, adult stem cells are quietly providing the basis for striking advances toward new therapies.